Boston Scientific Exec Says Sees 200-300 Bps Q4 Hit From Cyber Incident; Expects Q4 Organic Revenue Decline In The Range Of -1% To -3%; There Will Be Additional Price Headwinds In China In 2027, And The Growth Likely Won't Be Enough To Offset The Pressure From Ep And Watchman Next Year